In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Paul Dickinson, Founder and CSO at Seda Pharmaceutical Development Services. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Paul, covering: The success factors and a behind-the-scenes look at one of leading AstraZeneca’s fastest development programs – from the start of clinical trials to approval in just over two and a half years to meet unmet lung cancer needs How working with CROs and CDMOs led to identifying a poorly served nich ..read more

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jennifer Chadwick, CSO of ProtaGene. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jennifer, covering: Lessons and learnings moving from the world of academia into commercial industry The shift from lowest-price tactical outsourcing to value-based, holistic, and strategic outsourcing at a much earlier stage Nuances in the sandbox of playing with the buckets of CGTPs, and why emerging therapeutics do not play by the rules The incre ..read more

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Henal Shah, Life Sciences Lab Practice Head at Cognizant. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Henal, with a focus on: Decoding digital transformation and what it means for pharmaceutical companies across the life sciences supply chain Delivering fascinating insights into what a state-of-the-art smart factory and lab of the future look like The complexity of collating siloed data and connecting, orchestrating and presenti ..read more

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mark Bamforth, Entrepreneur, Mentor and Investor in life sciences. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Mark, covering: How an unsolicited offer led to the unplanned sale of Arranta Bio to global CDMO Recipharm Mark’s ability to spot trends of where the sector is going, and sometimes going against conventional wisdom How Mark thinks about investment in early stage and later stage companies, as an investor His take on the ..read more

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Raman Sehgal, covering his top tips for networking ahead of this year’s events season after 2 decades of learning the do's and don'ts, and making the mistakes for you. This episode covers; The importance of networking and how vital human interaction is to keep business going Being your own brand and understanding your network is your net worth Judging a book by its cover, and how that very thinking could cost you your next big deal Adding value without pushing for the hard ..read more

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Raman Sehgal for a special lookback episode on the topic of diversity in the life sciences space. This week’s episode features excerpts from conversations with; Barbara Morgan (Lubrizol at time of recording), now Global Vice President, Pharma and Biotechnology at Kerry discussing; gender diversity and the network of women supporting each other in their roles. Tia Lyles-Williams, founder & CEO at LucasPye Bio discussing; the recent political climate and how that has affe ..read more

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tom Ross, President and CEO at Grand River Aseptic Manufacturing (GRAM). Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tom, covering: How a passive investment in a small growing business led to running one of the most reputable CDMOs in the US Insights of how to pivot from lumpy clinical supply to sustainable commercial revenues The ups and downs, opportunities and challenges of growing a business at over 700pc+ as one of Inc Maga ..read more

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ian Tzeng, Managing Director at L.E.K. Consulting. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ian, covering: Insights, trends and advice for CROs, CDMOs and pharma services firms from one of the most prominent life science consultants. What he gained from his time studying at Harvard and the importance of genuine curiosity and a multi-disciplinary way of thinking. The complexity of modality and technology fragmentation, and the ..read more

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Claire Aldridge, Chief Strategy Officer at Form Bio. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Claire, covering: How a family ritual of solving puzzles played a role in developing an entrepreneurial spirit of problem solving Learn about how and why Northern Texas is becoming a destination for biotech and life sciences Going viral for being viral... and why covid was the time for immunologists to shine The opportunities and cha ..read more

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Harry Christiaens, CEO at Ardena. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Harry, covering: How a regulatory change led a small consultancy down the path of becoming one of Europe’s most respected mid-sized CDMOs The easy-theory of an M&A buy-and-build strategy, versus the challenging practical realities after acquiring and integrating five businesses Key considerations and questions you should ask before selecting a priv ..read more